Full-Time

Executive Director Portfolio Management Rare Disease

Posted on 4/13/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology

Senior

San Diego, CA, USA

Requirements
  • Bachelor’s degree in life science or related field; Advanced degree preferred
  • 15 years of progressively responsible, relevant experience focusing on program management with 10 years in a leadership role
  • Strong understanding of the drug development process
  • Experience managing cross-functional project teams
  • Knowledge of pharmaceutical program management
  • Rare Disease experience
  • Experience with Project Management tools and methodologies
  • Proficiency in Microsoft suite
Responsibilities
  • Lead Asset Strategy Teams for Rare Disease Franchise
  • Drive planning for key drug development stage-gate decision points
  • Manage an integrated program budget and resource plan
  • Facilitate resource planning and financial assessments
  • Coordinate formation of ASTs for Rare Disease Franchise programs
  • Collaborate with R&D Operations team
  • Conduct risk management and contingency planning
  • Lead decision analysis with the team
  • Ensure coordinated approach across portfolio managers

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals Inc. stands out as a leader in the niche field of neurological and mental health therapy development, particularly focusing on conditions like schizophrenia, Parkinson's disease psychosis, and Rett syndrome. This specialization not only brings significant advancement in targeted therapies but also enhances the quality of life for individuals enduring these challenging conditions. Working at this company offers the chance to be part of a dedicated team that positively impacts patient lives through groundbreaking work in a highly specialized area of medicine.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

San Diego, California

Founded

1993

Growth & Insights
Headcount

6 month growth

7%

1 year growth

14%

2 year growth

20%
INACTIVE